Causes of hospital readmissions after urologic cancer surgery

Standard

Causes of hospital readmissions after urologic cancer surgery. / Schmid, Marianne; Chiang, H Abraham; Sood, Akshay; Campbell, Logan; Chun, Felix K-H; Dalela, Deepansh; Okwara, James; Sammon, Jesse D; Kibel, Adam S; Menon, Mani; Fisch, Margit; Trinh, Quoc-Dien.

in: UROL ONCOL-SEMIN ORI, Jahrgang 34, Nr. 5, 05.2016, S. 236.e1-11.

Publikationen: SCORING: Beitrag in Fachzeitschrift/ZeitungSCORING: ZeitschriftenaufsatzForschungBegutachtung

Harvard

Schmid, M, Chiang, HA, Sood, A, Campbell, L, Chun, FK-H, Dalela, D, Okwara, J, Sammon, JD, Kibel, AS, Menon, M, Fisch, M & Trinh, Q-D 2016, 'Causes of hospital readmissions after urologic cancer surgery', UROL ONCOL-SEMIN ORI, Jg. 34, Nr. 5, S. 236.e1-11. https://doi.org/10.1016/j.urolonc.2015.11.019

APA

Schmid, M., Chiang, H. A., Sood, A., Campbell, L., Chun, F. K-H., Dalela, D., Okwara, J., Sammon, J. D., Kibel, A. S., Menon, M., Fisch, M., & Trinh, Q-D. (2016). Causes of hospital readmissions after urologic cancer surgery. UROL ONCOL-SEMIN ORI, 34(5), 236.e1-11. https://doi.org/10.1016/j.urolonc.2015.11.019

Vancouver

Schmid M, Chiang HA, Sood A, Campbell L, Chun FK-H, Dalela D et al. Causes of hospital readmissions after urologic cancer surgery. UROL ONCOL-SEMIN ORI. 2016 Mai;34(5):236.e1-11. https://doi.org/10.1016/j.urolonc.2015.11.019

Bibtex

@article{379eb233633f4a7f856f453660ef2c65,
title = "Causes of hospital readmissions after urologic cancer surgery",
abstract = "OBJECTIVES: The Hospital Readmissions Reduction Program mandates reimbursement reductions to hospitals with higher than expected rates of readmissions. We examine causes and predictors of readmissions following major procedures in urologic oncology.MATERIALS AND METHODS: Using the American College of Surgeons National Surgical Quality Improvement Program database, patients undergoing radical prostatectomy (RP), radical (RN) or partial nephrectomy (PN), and radical cystectomy (RC) during the year 2012 were abstracted. Rates of unplanned readmission within 30 days after surgery, as well as causes of readmission, were identified. Multivariable logistic regression models were fitted to examine the association between patient perioperative factors and odds of readmission.RESULTS: Overall, we observed a 5.5% unplanned 30-day readmission rate. Readmission rates for patients treated with RP, RN, PN, and RC were 4.1%, 5.2%, 4.5%, and 15.9%, respectively. For each procedure, approximately two-third of readmissions occurred within the first 10 days following hospital discharge. Commonest causes of readmission after RP included thromboembolic (13.6%), wound (12.2%), renal/genitourinary (12.2%), and gastrointestinal (11.8%); after RN, wound (12.9%) and gastrointestinal (12.9%); after PN, renal/genitourinary (19.6%), cardiovascular (9.8%), and bleeding/hematoma (9.8%); and after RC, renal/genitourinary (15.5%), wound (14.8%), and sepsis/infection (14.1%). RC was significantly associated with readmission. Patients undergoing open RP or PN were more likely to be readmitted relative to their minimally invasive counterparts (odds ratio = 1.53, 95% CI: 1.12-2.08, P = 0.007 and odds ratio = 2.51, 95% CI: 1.38-4.55, P = 0.003, respectively).CONCLUSIONS: Readmissions are relatively common following major urologic oncology procedures. Compared with RP, RN, or PN, RC patients experience the highest burden of readmission. Venous thromboembolism is a common modifiable cause of readmission following urologic cancer surgery. Minimally invasive approach is associated with decreased odds of readmission following RP and PN.",
keywords = "Aged, Cystectomy, Female, Humans, Logistic Models, Male, Middle Aged, Minimally Invasive Surgical Procedures, Multivariate Analysis, Nephrectomy, Patient Readmission, Postoperative Complications, Prostatectomy, Urologic Neoplasms, Venous Thromboembolism, Journal Article",
author = "Marianne Schmid and Chiang, {H Abraham} and Akshay Sood and Logan Campbell and Chun, {Felix K-H} and Deepansh Dalela and James Okwara and Sammon, {Jesse D} and Kibel, {Adam S} and Mani Menon and Margit Fisch and Quoc-Dien Trinh",
note = "Copyright {\textcopyright} 2016 Elsevier Inc. All rights reserved.",
year = "2016",
month = may,
doi = "10.1016/j.urolonc.2015.11.019",
language = "English",
volume = "34",
pages = "236.e1--11",
journal = "UROL ONCOL-SEMIN ORI",
issn = "1078-1439",
publisher = "Elsevier Inc.",
number = "5",

}

RIS

TY - JOUR

T1 - Causes of hospital readmissions after urologic cancer surgery

AU - Schmid, Marianne

AU - Chiang, H Abraham

AU - Sood, Akshay

AU - Campbell, Logan

AU - Chun, Felix K-H

AU - Dalela, Deepansh

AU - Okwara, James

AU - Sammon, Jesse D

AU - Kibel, Adam S

AU - Menon, Mani

AU - Fisch, Margit

AU - Trinh, Quoc-Dien

N1 - Copyright © 2016 Elsevier Inc. All rights reserved.

PY - 2016/5

Y1 - 2016/5

N2 - OBJECTIVES: The Hospital Readmissions Reduction Program mandates reimbursement reductions to hospitals with higher than expected rates of readmissions. We examine causes and predictors of readmissions following major procedures in urologic oncology.MATERIALS AND METHODS: Using the American College of Surgeons National Surgical Quality Improvement Program database, patients undergoing radical prostatectomy (RP), radical (RN) or partial nephrectomy (PN), and radical cystectomy (RC) during the year 2012 were abstracted. Rates of unplanned readmission within 30 days after surgery, as well as causes of readmission, were identified. Multivariable logistic regression models were fitted to examine the association between patient perioperative factors and odds of readmission.RESULTS: Overall, we observed a 5.5% unplanned 30-day readmission rate. Readmission rates for patients treated with RP, RN, PN, and RC were 4.1%, 5.2%, 4.5%, and 15.9%, respectively. For each procedure, approximately two-third of readmissions occurred within the first 10 days following hospital discharge. Commonest causes of readmission after RP included thromboembolic (13.6%), wound (12.2%), renal/genitourinary (12.2%), and gastrointestinal (11.8%); after RN, wound (12.9%) and gastrointestinal (12.9%); after PN, renal/genitourinary (19.6%), cardiovascular (9.8%), and bleeding/hematoma (9.8%); and after RC, renal/genitourinary (15.5%), wound (14.8%), and sepsis/infection (14.1%). RC was significantly associated with readmission. Patients undergoing open RP or PN were more likely to be readmitted relative to their minimally invasive counterparts (odds ratio = 1.53, 95% CI: 1.12-2.08, P = 0.007 and odds ratio = 2.51, 95% CI: 1.38-4.55, P = 0.003, respectively).CONCLUSIONS: Readmissions are relatively common following major urologic oncology procedures. Compared with RP, RN, or PN, RC patients experience the highest burden of readmission. Venous thromboembolism is a common modifiable cause of readmission following urologic cancer surgery. Minimally invasive approach is associated with decreased odds of readmission following RP and PN.

AB - OBJECTIVES: The Hospital Readmissions Reduction Program mandates reimbursement reductions to hospitals with higher than expected rates of readmissions. We examine causes and predictors of readmissions following major procedures in urologic oncology.MATERIALS AND METHODS: Using the American College of Surgeons National Surgical Quality Improvement Program database, patients undergoing radical prostatectomy (RP), radical (RN) or partial nephrectomy (PN), and radical cystectomy (RC) during the year 2012 were abstracted. Rates of unplanned readmission within 30 days after surgery, as well as causes of readmission, were identified. Multivariable logistic regression models were fitted to examine the association between patient perioperative factors and odds of readmission.RESULTS: Overall, we observed a 5.5% unplanned 30-day readmission rate. Readmission rates for patients treated with RP, RN, PN, and RC were 4.1%, 5.2%, 4.5%, and 15.9%, respectively. For each procedure, approximately two-third of readmissions occurred within the first 10 days following hospital discharge. Commonest causes of readmission after RP included thromboembolic (13.6%), wound (12.2%), renal/genitourinary (12.2%), and gastrointestinal (11.8%); after RN, wound (12.9%) and gastrointestinal (12.9%); after PN, renal/genitourinary (19.6%), cardiovascular (9.8%), and bleeding/hematoma (9.8%); and after RC, renal/genitourinary (15.5%), wound (14.8%), and sepsis/infection (14.1%). RC was significantly associated with readmission. Patients undergoing open RP or PN were more likely to be readmitted relative to their minimally invasive counterparts (odds ratio = 1.53, 95% CI: 1.12-2.08, P = 0.007 and odds ratio = 2.51, 95% CI: 1.38-4.55, P = 0.003, respectively).CONCLUSIONS: Readmissions are relatively common following major urologic oncology procedures. Compared with RP, RN, or PN, RC patients experience the highest burden of readmission. Venous thromboembolism is a common modifiable cause of readmission following urologic cancer surgery. Minimally invasive approach is associated with decreased odds of readmission following RP and PN.

KW - Aged

KW - Cystectomy

KW - Female

KW - Humans

KW - Logistic Models

KW - Male

KW - Middle Aged

KW - Minimally Invasive Surgical Procedures

KW - Multivariate Analysis

KW - Nephrectomy

KW - Patient Readmission

KW - Postoperative Complications

KW - Prostatectomy

KW - Urologic Neoplasms

KW - Venous Thromboembolism

KW - Journal Article

U2 - 10.1016/j.urolonc.2015.11.019

DO - 10.1016/j.urolonc.2015.11.019

M3 - SCORING: Journal article

C2 - 26712365

VL - 34

SP - 236.e1-11

JO - UROL ONCOL-SEMIN ORI

JF - UROL ONCOL-SEMIN ORI

SN - 1078-1439

IS - 5

ER -